May 13, 2026
Announcement
REVIVA PHARMACEUTICALS HOLDINGS INC announced a Change of Listing from NASDAQ to OTC on May 13, 2026. The Change of Listing is expected to be completed on May 14, 2026.
The treatment below will be applied to the following indices:
Solactive US Extended Broad Market Index (GTR)
We work closely with our internal partners to deliver investment ideas that generate demonstrable value for our clients.